A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
4-Hydroxytestosterone
Tramiprosate
The risk or severity of adverse effects can be increased when Tramiprosate is combined with Lemborexant.
4-Hydroxytestosterone
Deramciclane
The risk or severity of adverse effects can be increased when Deramciclane is combined with Lemborexant.
4-Hydroxytestosterone
Remacemide
The risk or severity of adverse effects can be increased when Remacemide is combined with Lemborexant.
4-Hydroxytestosterone
Dotarizine
The risk or severity of adverse effects can be increased when Dotarizine is combined with Lemborexant.
4-Hydroxytestosterone
Amisulpride
The risk or severity of adverse effects can be increased when Amisulpride is combined with Lemborexant.
4-Hydroxytestosterone
Ziconotide
The risk or severity of adverse effects can be increased when Ziconotide is combined with Lemborexant.
4-Hydroxytestosterone
Tolperisone
The risk or severity of adverse effects can be increased when Tolperisone is combined with Lemborexant.
4-Hydroxytestosterone
Lacosamide
The risk or severity of adverse effects can be increased when Lacosamide is combined with Lemborexant.
4-Hydroxytestosterone
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Lemborexant.
4-Hydroxytestosterone
Sertindole
The risk or severity of adverse effects can be increased when Sertindole is combined with Lemborexant.
4-Hydroxytestosterone
YKP-1358
The risk or severity of adverse effects can be increased when YKP-1358 is combined with Lemborexant.
4-Hydroxytestosterone
Lumateperone
The risk or severity of adverse effects can be increased when Lumateperone is combined with Lemborexant.
4-Hydroxytestosterone
Cariprazine
The risk or severity of adverse effects can be increased when Cariprazine is combined with Lemborexant.
4-Hydroxytestosterone
Gantacurium
The risk or severity of adverse effects can be increased when Gantacurium is combined with Lemborexant.
4-Hydroxytestosterone
BL-1020
The risk or severity of adverse effects can be increased when BL-1020 is combined with Lemborexant.
4-Hydroxytestosterone
PRX-08066
The risk or severity of adverse effects can be increased when PRX-08066 is combined with Lemborexant.
4-Hydroxytestosterone
Naluzotan
The risk or severity of adverse effects can be increased when Naluzotan is combined with Lemborexant.
4-Hydroxytestosterone
Naronapride
The risk or severity of adverse effects can be increased when Naronapride is combined with Lemborexant.
4-Hydroxytestosterone
Pimavanserin
The risk or severity of adverse effects can be increased when Pimavanserin is combined with Lemborexant.
4-Hydroxytestosterone
Methsuximide
The risk or severity of adverse effects can be increased when Methsuximide is combined with Lemborexant.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3